MRNAModerna, Inc.
140.30USD-19.54%Mkt Cap: 69.62B $P/E:

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal in…

Key Statistics

Company
Market Cap69.62B $
Enterprise Value49.38B $
Revenue (TTM)2.23B $
Gross Profit1.05B $
Net Income (TTM)-2.82B $
Revenue/Share5.662 USD
Last Price140.30 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.7K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS60770K1079
Valuation
P/E (Trailing)
P/E (Forward)-29.09
PEG
EV/EBITDA-22.49
EV/Revenue22.16
P/S23.89
P/B7.87
EPS (TTM)-6.11
EPS (Forward)-4.58
52W Range
22.2876% of range176.66
52W High176.66 USD
52W Low22.28 USD
Profitability
Gross Margin54.84%
Oper. Margin-557.93%
EBITDA Margin-98.52%
Profit Margin-146.83%
ROE-32.62%
ROA-22.87%
Growth
Revenue Growth2.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-1.87B $
CapEx (TTM)202.00M $
FCF Margin13.43%
FCF Yield0.43%
Net Debt-3.85B $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.15
Current Ratio2.29
Quick Ratio2.07
Book Value/Sh16.95 USD
Cash/Share12.87 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)89.33 USD
Upside (mean)-36.3%
Target Range25.00 USD170.00 USD
$25.00-36.3% to mean$170.00
# Analysts18
Ownership
Shares Out.399.24M
Float372.27M
Insiders7.32%
Institutions80.46%
Short Interest
Short Ratio7.2d
Short % Float15.23%
Short % Out.12.47%
Shares Short49.77M
Short (prev mo.)53.19M
Technical
SMA 5065.62 (+113.8%)
SMA 20048.13 (+191.5%)
Beta0.90
S&P 52W Chg18.16%
Avg Vol (30d)11.29M
Avg Vol (10d)34.57M
Technical Indicators
RSI (14)92.8
MACD9.5576
MACD Signal1.5602
MACD Hist.+7.9974
BB Upper116.39 USD
BB Middle63.95 USD
BB Lower11.52 USD
BB Width163.97%
ATR (14)11.50 USD
Vol Ratio (20d)36.08x